Michael J. Allegrezza

BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression

Hengrui Zhu, Fee Bengsch, Nikolaos Svoronos et al. · Cell Reports · 2016 · 417 citations · Full text

Cancer Immunosurveillance, Pd-l1 Expression, Pd-l1 Signaling +10

Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations

Curtis H. Kugel, Stephen M. Douglass, Marie R. Webster et al. · Clinical Cancer Research · 2018 · 347 citations · Full text

Microbially Driven TLR5-Dependent Signaling Governs Distal Malignant Progression through Tumor-Promoting Inflammation

Melanie R. Rutkowski, Tom L. Stephen, Nikolaos Svoronos et al. · Cancer Cell · 2014 · 301 citations · Full text

Inflammation, Cancer Immunosurveillance, Medicine +9

Tumor Cell–Independent Estrogen Signaling Drives Disease Progression through Mobilization of Myeloid-Derived Suppressor Cells

Nikolaos Svoronos, Alfredo Perales‐Puchalt, Michael J. Allegrezza et al. · Cancer Discovery · 2016 · 215 citations · Full text

SATB1 Expression Governs Epigenetic Repression of PD-1 in Tumor-Reactive T Cells

Tom L. Stephen, Kyle K. Payne, Ricardo A. Chaurio et al. · Immunity · 2017 · 151 citations · Full text

Tumor-reactive T Cells, Cancer Immunosurveillance, Epigenetic Regulation +9